Bright Minds Biosciences (DRUG.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov17

Bright Minds Biosciences Expands Scientific Advisory Board to Support PWS Project

11:51

Oct2

Shrader Maintains Strong Buy Rating on Bright Minds Biosciences

10:31

Aug15

Bright Minds Biosciences released FY2025 9 Months Earnings on August 14 EST, with actual revenue of USD 0 and EPS of USD -0.8279

03:00

Bright Minds Biosciences released FY2025 Q3 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5402 (forecast USD -0.5722)

03:00

May28

Bright Minds Biosciences to Speak at Jefferies 2025 Global Healthcare Conference

19:42

May21

Chardan Capital Maintains Bright Minds Biosciences Buy Rating

14:21

Schedules & Filings

Schedules

Filings

Aug14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.827 M, EPS -0.5402

May15

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.061 M, EPS -0.2933

Feb13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income 34.56 K, EPS 0.0056

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change